Purple Biotech (PPBT) EBITDA (2014 - 2026)
Purple Biotech (PPBT) reported EBITDA of $89000.0 for Q1 2026, down 80.48% year-over-year from $456000.0 in Q1 2025, and down 99.62% quarter-over-quarter from $23.6 million in Q4 2025.
Purple Biotech (PPBT) EBITDA (2014 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 13 years of EBITDA data on file, last reported at $89000.0 in Q1 2026.
- EBITDA for Q1 2026 came in at $89000.0, down 80.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $26.1 million (up 560.06% YoY), and the FY2025 annual result was $26.5 million, up 263.0% from the prior year.
- EBITDA slipped to $89000.0 in Q1 2026 per PPBT's latest filing, from $23.6 million in the prior quarter.
- Over five years, EBITDA peaked at $23.6 million in Q4 2025 and troughed at $89000.0 in Q1 2026.
- A 5-year average of $4.5 million and a median of $3.8 million in 2024 frame the typical range for EBITDA.
- The sharpest annual moves came in 2024 and 2025: EBITDA sank 91.46% in 2024, then soared 5624.46% in 2025.
- A 5-year view of EBITDA shows it stood at $6.0 million in 2022, then slipped by 19.79% to $4.8 million in 2023, then slumped by 91.46% to $413000.0 in 2024, then soared by 5624.46% to $23.6 million in 2025, then plunged by 99.62% to $89000.0 in 2026.
- Business Quant data shows PPBT's EBITDA at $89000.0 in Q1 2026, $23.6 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -14.44 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -65.83 Mn |
| 10 | Purple Biotech | 242.86 Mn | 236.43 Mn | - | 89,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89,000.00 |
| Dec 31, 2025 | 23.64 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 1.09 Mn |
| Mar 31, 2025 | 456,000.00 |
| Dec 31, 2024 | 413,000.00 |
| Sep 30, 2024 | 668,000.00 |
| Jun 30, 2024 | 2.42 Mn |
| Mar 31, 2024 | 3.80 Mn |
| Dec 31, 2023 | 4.84 Mn |
| Sep 30, 2023 | 5.06 Mn |
| Jun 30, 2023 | 5.16 Mn |
| Mar 31, 2023 | 4.90 Mn |
| Dec 31, 2022 | 6.03 Mn |
| Sep 30, 2022 | 4.85 Mn |
| Jun 30, 2022 | 3.57 Mn |
| Mar 31, 2022 | 7.38 Mn |
| Dec 31, 2021 | 5.11 Mn |
| Sep 30, 2021 | 3.15 Mn |
| Jun 30, 2021 | 3.64 Mn |